Your browser doesn't support javascript.
loading
Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
Romero, Alejandro; Ramos, Eva; López-Muñoz, Francisco; Gil-Martín, Emilio; Escames, Germaine; Reiter, Russel J.
Afiliação
  • Romero A; Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid, Avda. Puerta de Hierro s/n, 28040, Madrid, Spain. manarome@ucm.es.
  • Ramos E; Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid, Avda. Puerta de Hierro s/n, 28040, Madrid, Spain.
  • López-Muñoz F; Faculty of Health Sciences, University Camilo José Cela, C/ Castillo de Alarcón 49, 28692, Villanueva de la Cañada, Madrid, Spain.
  • Gil-Martín E; Neuropsychopharmacology Unit, Hospital 12 de Octubre Research Institute (i+12), Avda. Córdoba, s/n, 28041, Madrid, Spain.
  • Escames G; Portucalense Institute of Neuropsychology and Cognitive and Behavioural Neurosciences (INPP), Portucalense University, R. Dr. António Bernardino de Almeida 541, 4200-072, Porto, Portugal.
  • Reiter RJ; Thematic Network for Cooperative Health Research (RETICS), Addictive Disorders Network, Health Institute Carlos III, MICINN and FEDER, Madrid, Spain.
Cell Mol Neurobiol ; 42(3): 489-500, 2022 Apr.
Article em En | MEDLINE | ID: mdl-32772307
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema Nervoso Central / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 / Melatonina Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema Nervoso Central / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 / Melatonina Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article